A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation
Title:
A Single Center, Randomized, Open-Label, Controlled Pilot Study to Demonstrate Efficacy and Safety of the Addition of Inhaled Liposomal Cyclosporine (L-CsA) Therapy versus Standard Therapy Alone in the Treatment of Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplantation
Author:
Iacono, A. Terrin, M. Rajakopal, K. McGrain, J. Barr, E. Rinaldi, J. Patel, A. Timofte, I. Kim, J. Kon, Z. Sanchez, P.G. Pierson, R. Griffith, B. Pham, S.